SmartfIRE, the single-arm study evaluating the Johnson & Johnson/Biosense Webster Thermocool Smarttouch SF dual-energy catheter and Trupulse generator, has completed enrollment about four months after it started.
The trial has enrolled 149 patients with paroxysmal atrial fibrillation across nine centers in Europe, the company announced on 19...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?